Literature DB >> 18072105

Carisoprodol abuse in Texas, 1998-2003.

Mathias B Forrester1.   

Abstract

INTRODUCTION: Texas poison centers identified carisoprodol as a skeletal muscle relaxant that is subject to abuse, and this investigation explores the abuse reported by Texas poison centers.
METHODS: This study used data from six Texas poison centers to describe the epidemiology of carisoprodol abuse and drug identification (ID) calls from 1998 to 2003.
RESULTS: Drug ID and abuse calls were 217% higher in 2003 than in 1998. Although eastern and central Texas contains 43% of the state's population, this region reported 77% of all drug ID calls and 64% of abuse calls. For male patients, 51% of the calls were abuse calls and 37% were other human carisoprodol exposure calls. Patients from 13 to 19 years of age accounted for 17% of abuse calls and 9% of other human exposure calls. Among those human exposure calls with a known medical outcome, a higher percentage of abuse calls involved minor effects while a greater proportion of other human exposure calls involved outcomes that ranged from moderate effects to death.
CONCLUSIONS: Carisoprodol abuse is increasing in Texas and is substantially more common in the eastern part of the state. Carisoprodol abuse is much more likely, than other types of adverse carisoprodol exposures, to involve males and adolescents; and it less likely to involve adverse medical outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18072105      PMCID: PMC3550032          DOI: 10.1007/bf03161006

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  14 in total

1.  2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  William A Watson; Toby L Litovitz; George C Rodgers; Wendy Klein-Schwartz; Jessica Youniss; S Rutherfoord Rose; Douglas Borys; Mary E May
Journal:  Am J Emerg Med       Date:  2003-09       Impact factor: 2.469

2.  Surveillance of drug identification calls: an overlooked poison center responsibility.

Authors:  Rita Mrvos; Edward P Krenzelok
Journal:  Vet Hum Toxicol       Date:  2002-10

3.  Carisoprodol: an unrecognized drug of abuse.

Authors:  David N Bailey; John R Briggs
Journal:  Am J Clin Pathol       Date:  2002-03       Impact factor: 2.493

4.  Carisoprodol, meprobamate, and driving impairment.

Authors:  B K Logan; G A Case; A M Gordon
Journal:  J Forensic Sci       Date:  2000-05       Impact factor: 1.832

5.  Somatic dysfunction during carisoprodol cessation: evidence for a carisoprodol withdrawal syndrome.

Authors:  Roy R Reeves; Jefferson D Parker
Journal:  J Am Osteopath Assoc       Date:  2003-02

6.  Abuse of combinations of carisoprodol and tramadol.

Authors:  R R Reeves; V Liberto
Journal:  South Med J       Date:  2001-05       Impact factor: 0.954

7.  Carisoprodol intoxications and serotonergic features.

Authors:  Jørgen G Bramness; Jørg Mørland; Hanne Kristin Sørlid; Nina Rudberg; Dag Jacobsen
Journal:  Clin Toxicol (Phila)       Date:  2005       Impact factor: 4.467

Review 8.  Carisoprodol (Soma): a new and cautious perspective on an old agent.

Authors:  R A Littrell; L R Hayes; V Stillner
Journal:  South Med J       Date:  1993-07       Impact factor: 0.954

9.  Meprobamate dependence secondary to carisoprodol (Soma) use.

Authors:  R A Littrell; T Sage; W Miller
Journal:  Am J Drug Alcohol Abuse       Date:  1993       Impact factor: 3.829

10.  Carisoprodol as a drug of abuse.

Authors:  G S Rust; R Hatch; J G Gums
Journal:  Arch Fam Med       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.